Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France

  • STATUS
    Recruiting
  • End date
    Sep 18, 2026
  • participants needed
    150
  • sponsor
    Sanofi
Send
Updated on 6 February 2025
See if I qualify

Summary

This is a multicentre, non-interventional, single arm study that aims to describe the treatment patterns in France: patients' characteristics, disease characteristics, prior treatments for Severe chronic rhinosinusitis with nasal polyposis and treatment prescription modalities. As well as to assess the clinical outcome after initiation of dupilumab (Dupixent®) and safety of the product during the two years of treatment

Details
Condition Chronic Rhinosinusitis With Nasal Polyposis
Age 18years or above
Treatment Dupilumab
Clinical Study IdentifierNCT06393946
SponsorSanofi
Last Modified on6 February 2025

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patient aged >= 18 years old at the time of the initiation of the treatment with dupilumab (Dupixent®)
Decision to initiate Dupixent® prior to inclusion in the study, initiation of Dupixent® for severe Chronic rhinosinusitis with nasal polyposis (CRSwNP) maximum 3 months before inclusion
Informed consent and willingness to participate

Exclusion Criteria

Conditions or legal situations resulting in impossibility to consent or impacting the interpretation of the results
Patient participating in an interventional clinical trial with experimental product at inclusion
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
US Only: Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.